Wikisage, the free encyclopedia of the second generation, is digital heritage

Difference between revisions of "Doripenem"

From Wikisage
Jump to navigation Jump to search
(ATC)
 
(One intermediate revision by the same user not shown)
Line 11: Line 11:
 
{| style="background:Ivory; color:black" border=1 cellspacing=1 cellpadding=5
 
{| style="background:Ivory; color:black" border=1 cellspacing=1 cellpadding=5
 
|colspan=2| <center>
 
|colspan=2| <center>
<gallery>File:none.png</gallery>
+
[[File:Doripenem_vert1.jpg|292px]]
 
: [[wikipedia:doripenem|doripenem]]
 
: [[wikipedia:doripenem|doripenem]]
 
<ref>[https://www.whocc.no/atc_ddd_index/?code=J01DH04 J01DH04]</ref></center>
 
<ref>[https://www.whocc.no/atc_ddd_index/?code=J01DH04 J01DH04]</ref></center>
 
|}
 
|}
<ref>[https://karmel.miraheze.org/m/6Sy karnmel(miraheze) es:Doripenem]</ref>
+
<ref>[https://karmel.miraheze.org/m/6Sy karmel(miraheze) es:Doripenem]</ref>
  
 
{{refs}}
 
{{refs}}

Latest revision as of 21:28, 2 September 2021

Doripenem is a beta-lactam antibiotic agent belonging to the carbapenem group

Seizures have been reported during treatment with doripenem (see section 6.2). In clinical trials, doripenem-treated patients with pre-existing central nervous system (CNS) disorders (e.g. stroke or history of seizures), patients with compromised renal function and patients given doses greater than 500 mg every 8 hours appear to be at greater risk for developing seizures [1]

Q411552 op Wikidata  Interwiki via Wikidata

ATC

Doripenem vert1.jpg

doripenem
[2]

[3]

References

References: